Mireille Gillings

Source: Wikipedia, the free encyclopedia.

Mireille Gillings
Mireille Gillings
Born
Montreal, Quebec, Canada
NationalityCanadian
Education
Occupation(s)
entrepreneur
SpouseSir Dennis Gillings (m. 2012)

Mireille Gingras Gillings, (born 1962) is a US-based Canadian

San Diego, California, company's CEO and Executive Chair. The company has offices in Pudong, Shanghai, China.[1][2]

In 2010, Gillings' interest in China as a source of "research-intensive, expensive-to-develop medicines that are the stuff of patents and high profit margins" attracted the interest of Fortune magazine.[3]

Born in

Concordia University.[4]

Also one of the founders of MIR3,


Philanthropy

In 2019 the French Government awarded Dr. Gillings its highest national award, the Knight of the Legion of Honor, in recognition of her contributions to neuroscience, entrepreneurship and philanthropy.

Personal life

In 2012, she married Dennis Gillings in Hawaii.[8]

References

  1. ^ Welcome Message from CEO and founder Mireille Gillings, PhD (accessed 6 November 2010)
  2. ^ Poh, Alissa (13 November 2008). "HUYA: A conduit between Chinese pharma and US clinical trials". PharmaWeek. Archived from the original on 7 May 2010. Retrieved 6 November 2010.
  3. ^ Powell, Bill (15 November 2010). "Biotech pioneers: How two unlikely partners plan to unleash China's young pharma industry". Fortune. Vol. 182, no. 8. pp. 49–50, 52. Retrieved 6 November 2010. The quotation appears on p. 50.
  4. ^ "Executive Team - HUYA Bioscience International". Archived from the original on 10 May 2018. Retrieved 14 June 2017.
  5. ^ HUYA profile on Bloomberg Business Week[dead link] (accessed 6 November 2010); see also the MIR3 site
  6. ^ Dolgin, Elie (June 2009). "Year of the compound: Will a novel codevelopment model open up China's drug discovery platform?". Scientist. Vol. 23, no. 6. p. 57. Archived from the original on 26 August 2012. Retrieved 6 November 2010. The article explains that the name HUYA comes from the "Chinese abbreviations for Shanghai (Hù) and Asia (Yà)"; the name is pronounced in English like WHO YA with equal stress on both syllables (/'hu·'ja/).
  7. ^ David, Gollaher; Gingras, Mirielle (9 February 2010). "HUYA Bioscience International". CHI: Advancing California Biomedical Research and Innovation. Retrieved 6 November 2010.
  8. ^ Gibson, Dale (7 September 2012). "Gillings remarries; new bride heads California pharma". www.bizjournals.com.